Cambria Cannabis ETF

Philip Morris International Options Trading Shows Investor Optimism

Tower Bridge Advisors Increases Position in Philip Morris International

Village Farms to release FY2025 Q4 earnings on March 12 Pre-Market EST, forecast revenue USD 59.57 M, EPS USD 0.05

Turning Point Brands released FY2025 Q4 earnings on March 2 Pre-Market (EST), actual revenue USD 121.01 M (forecast USD 120.42 M), actual EPS USD 0.42 (forecast USD 0.87)

Turning Point Brands released FY2025 earnings on March 2 Pre-Market EST, actual revenue USD 463.06 M (forecast USD 462.48 M), actual EPS USD 3.11 (forecast USD 3.575)

Cronos released FY2025 annual earnings on February 26 Pre-Market EST, actual revenue USD 146.59 M (forecast USD 139.34 M), actual EPS USD -0.02 (forecast USD -0.0034)

Cronos released FY2025 Q4 earnings on February 26 Pre-Market EST, actual revenue USD 44.53 M (forecast USD 39.77 M), actual EPS USD -0.0047 (forecast USD 0.0165)

Fitch Confirms Philip Morris International's Rating

Turning Point Brands to Release FY2025 Q4 Earnings on March 2, 2026 Pre-Market EST, Forecast Revenue USD 120.42M, EPS USD 0.87

Philip Morris International CEO Jacek Olczak Sells Company's Shares

Philip Morris International CEO Sells Company Shares

Cronos to Release FY2025 Q4 Earnings on February 26, 2026 Pre-Market EST, Forecast Revenue USD 39.37 M, EPS USD 0.0149

Philip Morris International Outlines 2026-2028 Financial Projections

Philip Morris International Reaffirms 2026 Earnings Outlook

Philip Morris Provides 2023 EPS Outlook

Atria Investments Inc. Increased Holdings in Philip Morris International Inc.

Philip Morris lobbying India to ease e-cigarette ban

Cibc World Market Inc. Increased Holdings in Philip Morris International in Q3

Citigroup Raises Philip Morris Target Price to $210 and Maintains 'Buy' Rating

FactSet Survey Shows Philip Morris International Target Price Revised Up to $192

Peraso

QUARTZSEA ACQUISITION CORP ORD USD0.0001 (18/02/2030) (S/R)

Decent

Edesa Biotech

Cre8 Enterprise - CL

AN2 Therapeutics

Day One Biopharmaceuticals

Epsium Enterprise

Silynxcom

Aptera Motors - B

TOKE

CNBS

YOLO

The cannabis industry faces a reckoning as federal regulations tighten around hemp-derived THC products. Executives who rushed into the market may regret their decisions as the FDA prepares to enforce stricter rules, including cease-and-desist letters. While many companies focused on quick profits from intoxicating cannabinoid products, MMJ International Holdings took a different approach by developing FDA-compliant cannabinoid medicines. This divide could lead to a significant shift in the industry, favoring those who prioritize clinical validation over consumer brands.

Acceswire

Amplify Alternative Harvest ETF

Amplify Seymour Cannabis ETF

AdvisorShares Pure Cannabis ETF

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry's Reckoning Is Coming

OILK

CANE

Surging Crude Oil Supports Sugar Prices

Barchart Option

United States Oil Fund LP

ISHRS S&P Glb Engy

Pro K1 Free Crude Oil

Teucrium Sugar

VanEck Oil Services ETF

iShares US Oil & Gas Expl & Prod

SPDR Energy Select

SPDR O&G Ex & Prd

Surging Crude Oil Supports Sugar Prices

SOYB

Chicago Board of Trade soybean futures rose on March 5, driven by higher crude oil prices amid ongoing Middle East supply disruptions. Crude oil's increase led to reduced refinery output globally. While grain markets typically respond to crude oil fluctuations, ample global crop supply and a strong dollar limited price gains. Brazil's record soybean harvest may impact Chinese demand for U.S. beans. The USDA reported U.S. soybean export sales at 383,500 metric tons, exceeding analyst expectations. CBOT May soybeans closed at $11.79-1/4 per bushel, while soyoil reached lifetime highs.

Reuters

Pro Ultr Bloomberg Crude Oil

Teucrium Soybean

CBOT soybeans gain as crude oil rallies

MSOS

Splash Beverage Group has signed a non-binding letter of intent to merge with Medterra, a CBD operator that reported over $52 million in revenue for fiscal 2025. The merger aims to rebrand Splash as a cannabinoid wellness platform, focusing on scalable brand development. The transaction is subject to definitive agreements, shareholder and NYSE American approvals, and other customary closing conditions. Medterra's established operations and profitability enhance the merger's potential.

TradingView

AdvisorShares Pure US Cannabis ETF

Splash Beverage Group signs LOI to combine with Medterra; Medterra FY2025 revenue > $52M

IBBQ

The global collagen hydrolysates market is projected to grow from USD 1.4 billion in 2026 to USD 3.0 billion by 2036, with a CAGR of 7.8%. This growth is driven by a shift towards bioactive peptides and fermentation-derived alternatives, as consumers demand clinical validation for health benefits. The market is dominated by animal-based sources, particularly in nutraceuticals, with significant growth in the Asia-Pacific region, especially China and Japan. Key players include Gelita AG and Rousselot, focusing on bioactive ingredients and sustainable practices.

MorningStar

Invesco Nasdaq Biotechnology ETF

Darling Ingredients

iShares Biotechnology ETF

Collagen Hydrolysates Market Projected to Reach USD 3.0 Billion by 2036 as Clinical Validation and Biotech Innovation Redefine Wellness

Soybeans Easing Lower to Early on Wednesday

WisdomTree Soybeans

Soybeans Easing Lower to Early on Wednesday

The rising popularity of tinned fish is challenged by sustainable sourcing due to increasing ocean temperatures. Climate change is impacting marine ecosystems, affecting fish availability. As demand grows, producers must find sustainable sources while adapting to environmental changes that alter fish habitats and migration patterns. This highlights the urgent need for innovative solutions to ensure the long-term viability of tinned fish production.

CoinLive

Sustainable Sourcing Challenges for Tinned Fish Amid Rising Ocean Temperatures

WEED

The Trump administration signals that cannabis rescheduling is progressing, potentially boosting cannabis stocks. Rescheduling would move cannabis to Schedule III, allowing companies to deduct operating expenses. Recent positive signals include the White House's commitment to rescheduling despite criticism, FDA Commissioner affirming intent to promote medical research, and Trump's pardons of cannabis-related convictions. Investors remain optimistic about a significant market bounce upon rescheduling news.

CabotWealthNetwork

Roundhill Cannabis ETF

Cannabis Rescheduling Remains on Track

King Palm has expanded its collaboration with Hemp Living to include four diamond-infused THCA pre-roll strains following strong demand for the initial launch. The new flavors, Candy Runtz and Cadillac Rainbow, join the original Lambo and Gush Mintz strains. Each pre-roll contains approximately 40% THCA and less than 0.3% Delta-9 THC, complying with the 2018 Farm Bill. The products are available nationwide through Hemp Living Wholesale and participating retail smoke shops. King Palm is known for its natural smoking alternatives, while Hemp Living focuses on compliance and quality in hemp product manufacturing.

King Palm and Hemp Living Expand THCA Pre-Roll Collaboration Following Successful Initial Launch

MJUS

Leading Retirement Solutions (LRS) has released the first comprehensive Cannabis Industry Retirement Report, analyzing 140 cannabis 401(k) plans across over 420 entities, representing 17,000 participants and $71 million in assets. Key findings include 74% of plans offering auto-enrollment, with nearly 40% employee participation. The report highlights the industry's progress in providing competitive retirement benefits, which are becoming essential for attracting talent. Additionally, recent federal policy changes may enhance financial stability for cannabis operators, allowing for better employee benefits. This marks a significant shift in the cannabis industry's approach to retirement planning.

prnewswire

Amplify US Alternative Harvest ETF

11:42 ETA New Era for Cannabis: Inside the First Industry Retirement Report

FTXG

Bayou City Hemp Company (BCH) has launched a funding round aimed at accelerating its expansion in the THC beverage market, which is projected to reach $30 billion. The company has experienced significant growth, achieving 8x distribution revenue growth and plans to expand its distribution network from 15 to 40 states by 2026. BCH's strategy focuses on compliance and retail partnerships, positioning it as a leader in the evolving regulatory landscape. The funding will support BCH's goal of 200% revenue growth in 2026, while advocating for sensible federal regulations.

Invesco Food & Beverage ETF

First Trust NASDAQ Food & Beverage

08:56 ETBayou City Hemp Launches Funding Round to Fuel 200% Growth and Dominate $30B THC Beverage Boom with Retail Powerhouse Edge

TLRY

CRLBF

Delta Beverages, LLC has introduced a new Blood Orange Vanilla cannabis beverage which contains 10mg of THC and 2mg of CBD per serving. This latest innovation from the brand has been released in Charlotte, N.C. on February 5, 2026. Delta Beverages, LLC is currently the top THC drink brand in the U.S. based on volume and is now broadening its product range with this new addition.

Unusual Whales

Tilray Brands

Cresco Labs Inc.

Delta Beverages launched a new cannabis spirit with blood orange vanilla flavor, providing 10mg THC and 2mg CBD per serving.

TCNNF

In Oldwick, New Jersey, a recent executive order by the Trump administration aims to expedite the reclassification of marijuana under federal law, potentially bringing significant impacts to cannabis-related businesses. Currently, these businesses face challenges in obtaining specialized insurance coverage due to the complex underwriting process. The order signed by President Trump is geared towards advancing research on medical marijuana, which could result in improved understanding of the industry.

Trulieve Cannabis Corp.

Canopy Growth

Curaleaf Holdings, Inc.

SNDL

Innovative Industrial Properties

Cronos

Green Thumb Industries Inc.

Trump's exec order aims to fast track marijuana reclassification, may stabilize market; changes likely for related businesses.

Over 100 meetings were organized by the U.S. Hemp Roundtable (USHR) as industry leaders, farmers, and advocates gathered in Washington, D.C. to engage with lawmakers. The focus was on crucial extensions needed for the upcoming 2026 planting season. The meetings aimed to discuss legislative matters that are vital for the industry's growth and development. This initiative highlights the significance of collaboration between stakeholders and policymakers in shaping the future of hemp production in the United States.

U.S. Hemp Roundtable leads 100+ meetings on Capitol Hill, urging extensions crucial for 2026 planting season.

SynBiotic SE announced its strategy to align with regulatory clarity, operational excellence, and sustainable growth in the evolving cannabis market. The company will monitor regulatory developments, particularly in the U.S., and aims to benefit from the opening cannabis market in Europe and Germany. SynBiotic SE emphasizes investment in research, adherence to quality standards, and engagement with regulatory changes to support a regulated cannabis market.

SynBiotic SE to Align Strategy with Regulatory Clarity, Operational Excellence, and Sustainable Growth Amid Evolving Cannabis Market Dynamics

Cambria Cannabis ETF(TOKE.US)

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry's Reckoning Is Coming

Surging Crude Oil Supports Sugar Prices

CBOT soybeans gain as crude oil rallies

Splash Beverage Group signs LOI to combine with Medterra; Medterra FY2025 revenue > $52M

Collagen Hydrolysates Market Projected to Reach USD 3.0 Billion by 2036 as Clinical Validation and Biotech Innovation Redefine Wellness